Managing Vancouver B1 fractures by cerclage system compared to locking plate fixation - a biomechanical study.
Katharina Gordon, Martin Winkler, Thomas Hofstädter...
https://pubmed.ncbi.nlm.nih.gov/27338228/Actively Recruiting
Led by Quanta Medical · Updated on 2025-03-20
202
Participants Needed
15
Research Sites
130 weeks
Total Duration
Researchers are investigating the use of a new polymer cerclage system called OrthoLoop in managing fractures of the femur and humerus bones, including those around prosthetic hips and shoulders. This study compares OrthoLoop to standard cerclage systems, mainly metallic ones, to see if it improves bone healing and reduces complications. The study focuses on adults aged 18 and older who require cerclage wiring as part of their fracture treatment. Participants receive either the OrthoLoop polymer cerclage device or a standard cerclage system after surgical repair of their fracture. The study is designed with two groups and follows patients for 36 months after surgery. Follow-up visits are scheduled at 6-8 weeks, 3 months, 6 months, and 36 months to monitor healing, pain, device performance, and any complications. During the study, researchers evaluate bone healing success six months after surgery, track the rate and timing of bone union, and observe any rupture or movement of the cerclage devices. Pain levels and surgical details are recorded at multiple intervals. The study also collects data on complications and surgeon satisfaction with the devices. This thorough follow-up aims to provide a detailed assessment of the OrthoLoop system compared to standard care over three years.
CONDITIONS
Study of the Effectiveness of a Polymer Cerclage System Compared to Cerclages Used in Standard Care (CERCPMCF) )
M
Marc Saab, Dr
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Quanta Medical
Lead Sponsor
Cousin Biotech
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Day 0 (surgery day)
Participants undergo implantation of the assigned cerclage system (Polymer Cerclage System OrthoLoop or standard cerclage) during surgery.
1 visit (surgical procedure)
Duration - Up to 36 months post-surgery
Participants are followed for up to 36 months after surgery to assess healing, complications, pain, and device performance.
Visits at 6-8 weeks, 3 months, 6 months, and 36 months post-surgery
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Katharina Gordon, Martin Winkler, Thomas Hofstädter...
https://pubmed.ncbi.nlm.nih.gov/27338228/Andrea Angelini, Concetto Battiato
https://pubmed.ncbi.nlm.nih.gov/26983607/Thomas Ferbert, Ayham Jaber, Nathan Gress...
https://pubmed.ncbi.nlm.nih.gov/31096789/Aaron J Altenburg, John J Callaghan, Tameem M Yehyawi...
https://pubmed.ncbi.nlm.nih.gov/19571089/Ian Peeters, Amalfi Depover, Alexander Van Tongel...
https://pubmed.ncbi.nlm.nih.gov/31326103/Nabil A Ebraheim, Kyle R Sochacki, Xiaochen Liu...
https://pubmed.ncbi.nlm.nih.gov/24002835/Andrea Angelini, Concetto Battiato
https://pubmed.ncbi.nlm.nih.gov/25186972/Hans Lindahl
https://pubmed.ncbi.nlm.nih.gov/17477925/Eleftherios Tsiridis, George Pavlou, Ramakrishnan Venkatesh...
https://pubmed.ncbi.nlm.nih.gov/19462362/C D Silverton, J J Jacobs, A G Rosenberg...
https://pubmed.ncbi.nlm.nih.gov/8792246/Quanta Medical
Lead Sponsor
Cousin Biotech
Collaborating Sponsor